CC
GRNA

Centiva Capital’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Centiva Capital’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,000
Closed -$294K – 1710
2021
Q2 		$294K Buy
+30,000
New +$292K 0.01% 1051

Other funds holding GRNA

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Centiva Capital's GRNA Position: Q3 2021 in Review

Centiva Capital sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2021, closing a stake of 30,000 shares — an estimated $294K sold.

Centiva Capital first reported a position in GRNA in Q2 2021 and held it in 1 quarter. The position peaked at $294K in Q2 2021. 70 funds tracked by Wall St. Rank hold GRNA as of Q3 2021.

  • Centiva Capital reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2021 after selling out during the quarter.
  • Centiva Capital sold 30,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2021, an estimated $294K.
  • Centiva Capital first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 1 quarter.
  • Centiva Capital's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $294K in Q2 2021.
  • 70 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.